Suchbegriffe: MULTIPLE SCLEROSIS - DIAGNOSIS , . Treffer: 47
Leurs, CE; Twaalfhoven, H; Lissenberg-Witte, BI; van, Pesch, V; Dujmovic, I; Drulovic, J; Castellazzi, M; Bellini, T; Pugliatti, M; Kuhle, J; Villar, LM; Alvarez-Cermeño, JC; Alvarez-Lafuente, R; Hegen, H; Deisenhammer, F; Walchhofer, LM; Thouvenot, E; Comabella, M; Montalban, X; Vécsei, L; Rajda, C; Galimberti, D; Scarpini, E; Altintas, A; Rejdak, K; Frederiksen, JL; Pihl-Jensen, G; Jensen, P; Khalil, M; Voortman, MM; Fazekas, F; Saiz, A; La, Puma, D; Vercammen, M; Vanopdenbosch, L; Uitdehaag, B; Killestein, J; Bridel, C; Teunissen, C
Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.
Mult Scler. 2020; 26(8):912-923
Doi: 10.1177/1352458519845844
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Fabian, E; Schiller, D; Toplak, H; Brunner-Krainz, M; Fazekas, F; Schoefl, R; Krejs, GJ
Clinical-Pathological Conference Series from the Medical University of Graz : Case No 153: A 55-year-old woman with atypical multiple sclerosis and irritable bowel syndrome.
Wien Klin Wochenschr. 2018; 130(3-4):151-160
Doi: 10.1007/s00508-017-1291-y
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hottenrott, T; Dersch, R; Berger, B; Endres, D; Huzly, D; Thiel, J; Rauer, S; Stich, O; Salzer, U; Venhoff, N
The MRZ reaction helps to distinguish rheumatologic disorders with central nervous involvement from multiple sclerosis.
BMC NEUROL. 2018; 18(1): 14
Doi: 10.1186/s12883-018-1018-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Thompson, AJ; Banwell, BL; Barkhof, F; Carroll, WM; Coetzee, T; Comi, G; Correale, J; Fazekas, F; Filippi, M; Freedman, MS; Fujihara, K; Galetta, SL; Hartung, HP; Kappos, L; Lublin, FD; Marrie, RA; Miller, AE; Miller, DH; Montalban, X; Mowry, EM; Sorensen, PS; Tintoré, M; Traboulsee, AL; Trojano, M; Uitdehaag, BMJ; Vukusic, S; Waubant, E; Weinshenker, BG; Reingold, SC; Cohen, JA
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.
Lancet Neurol. 2018; 17(2):162-173
Doi: 10.1016/S1474-4422(17)30470-2
Web of Science
PubMed
FullText
FullText_MUG
Brownlee, WJ; Hardy, TA; Fazekas, F; Miller, DH
Diagnosis of multiple sclerosis: progress and challenges.
Lancet. 2017; 389(10076):1336-1346
Doi: 10.1016/S0140-6736(16)30959-X
Web of Science
PubMed
FullText
FullText_MUG
Ropele, S; Enzinger, C; Fazekas, F
Iron Mapping in Multiple Sclerosis.
Neuroimaging Clin N Am. 2017; 27(2):335-342
Doi: 10.1016/j.nic.2016.12.003
Web of Science
PubMed
FullText
FullText_MUG
Baumann, M; Sahin, K; Lechner, C; Hennes, EM; Schanda, K; Mader, S; Karenfort, M; Selch, C; Häusler, M; Eisenkölbl, A; Salandin, M; Gruber-Sedlmayr, U; Blaschek, A; Kraus, V; Leiz, S; Finsterwalder, J; Gotwald, T; Kuchukhidze, G; Berger, T; Reindl, M; Rostásy, K
Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein.
J Neurol Neurosurg Psychiatry. 2015; 86(3):265-272
Doi: 10.1136/jnnp-2014-308346
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Gass, A; Rocca, MA; Agosta, F; Ciccarelli, O; Chard, D; Valsasina, P; Brooks, JC; Bischof, A; Eisele, P; Kappos, L; Barkhof, F; Filippi, M; MAGNIMS Study Group
MRI monitoring of pathological changes in the spinal cord in patients with multiple sclerosis.
Lancet Neurol. 2015; 14(4): 443-454.
Doi: 10.1016/S1474-4422(14)70294-7
Web of Science
PubMed
FullText
FullText_MUG
Rocca, MA; Amato, MP; De Stefano, N; Enzinger, C; Geurts, JJ; Penner, IK; Rovira, A; Sumowski, JF; Valsasina, P; Filippi, M; MAGNIMS Study Group
Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis.
Lancet Neurol. 2015; 14(3):302-317
Doi: 10.1016/S1474-4422(14)70250-9
Web of Science
PubMed
FullText
FullText_MUG
Rovira, À; Wattjes, MP; Tintoré, M; Tur, C; Yousry, TA; Sormani, MP; De Stefano, N; Filippi, M; Auger, C; Rocca, MA; Barkhof, F; Fazekas, F; Kappos, L; Polman, C; Miller, D; Montalban, X; MAGNIMS study group
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process.
Nat Rev Neurol. 2015; 11(8):471-482
Doi: 10.1038/nrneurol.2015.106
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Wattjes, MP; Rovira, À; Miller, D; Yousry, TA; Sormani, MP; de Stefano, MP; Tintoré, M; Auger, C; Tur, C; Filippi, M; Rocca, MA; Fazekas, F; Kappos, L; Polman, C; Frederik Barkhof, C; Xavier Montalban, C; MAGNIMS study group
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients.
Nat Rev Neurol. 2015; 11(10):597-606
Doi: 10.1038/nrneurol.2015.157
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Assaf, AT; Jürgens, TP; Benecke, AW; Riecke, B; Blessmann, M; Zrnc, TA; Much, CC; Heiland, M; Friedrich, RE
Numb chin syndrome: a rare and often overlooked symptom.
J Oral Facial Pain Headache. 2014; 28(1): 80-90.
Doi: 10.11607/jop.994
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kapfhammer, HP
[Coexistent depressive and anxiety disorders in epilepsy and multiple sclerosis: a challenge to neuropsychiatric practice].
Neuropsychiatr. 2014; 28(3):142-150
Doi: 10.1007/s40211-014-0105-y
PubMed
FullText
FullText_MUG
Robier, C; Amouzadeh-Ghadikolai, O; Bregant, C; Diez, J; Melinz, K; Neubauer, M; Quasthoff, S
The anti-VLA-4 antibody natalizumab induces erythroblastaemia in the majority of the treated patients with multiple sclerosis.
Mult Scler. 2014; 20(9):1269-1272
Doi: 10.1177/1352458514521307
Web of Science
PubMed
FullText
FullText_MUG
Kau, T; Taschwer, M; Deutschmann, H; Schönfelder, M; Weber, JR; Hausegger, KA
The "central vein sign": is there a place for susceptibility weighted imaging in possible multiple sclerosis?
Eur Radiol. 2013; 23(7):1956-1962
Doi: 10.1007/s00330-013-2791-4
Web of Science
PubMed
FullText
FullText_MUG
Teunissen, C; Menge, T; Altintas, A; Álvarez-Cermeño, JC; Bertolotto, A; Berven, FS; Brundin, L; Comabella, M; Degn, M; Deisenhammer, F; Fazekas, F; Franciotta, D; Frederiksen, JL; Galimberti, D; Gnanapavan, S; Hegen, H; Hemmer, B; Hintzen, R; Hughes, S; Iacobaeus, E; Kroksveen, AC; Kuhle, J; Richert, J; Tumani, H; Villar, LM; Drulovic, J; Dujmovic, I; Khalil, M; Bartos, A
Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis.
Mult Scler. 2013; 19(13):1802-1809
Doi: 10.1177/1352458513488232
Web of Science
PubMed
FullText
FullText_MUG
Wallner-Blazek, M; Rovira, A; Fillipp, M; Rocca, MA; Miller, DH; Schmierer, K; Frederiksen, J; Gass, A; Gama, H; Tilbery, CP; Rocha, AJ; Flores, J; Barkhof, F; Seewann, A; Palace, J; Yousry, T; Montalban, X; Enzinger, C; Fazekas, F
Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis.
J Neurol. 2013; 260(8):2016-2022
Doi: 10.1007/s00415-013-6918-y
Web of Science
PubMed
FullText
FullText_MUG
Filippi, M; Rocca, MA; Barkhof, F; Bakshi, R; Fazekas, F; Khan, O; Pelletier, D; Rovira, A; Simon, J
Multiple sclerosis and chronic cerebrospinal venous insufficiency: the neuroimaging perspective.
AJNR Am J Neuroradiol. 2011; 32(3):424-427
Doi: 10.3174/ajnr.A2348
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Loitfelder, M; Fazekas, F; Petrovic, K; Fuchs, S; Ropele, S; Wallner-Blazek, M; Jehna, M; Aspeck, E; Khalil, M; Schmidt, R; Neuper, C; Enzinger, C
Reorganization in cognitive networks with progression of multiple sclerosis: insights from fMRI.
Neurology. 2011; 76(6): 526-533.
Doi: 10.1212/WNL.0b013e31820b75cf
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Pagani, E; Hirsch, JG; Pouwels, PJ; Horsfield, MA; Perego, E; Gass, A; Roosendaal, SD; Barkhof, F; Agosta, F; Rovaris, M; Caputo, D; Giorgio, A; Palace, J; Marino, S; De Stefano, N; Ropele, S; Fazekas, F; Filippi, M
Intercenter differences in diffusion tensor MRI acquisition.
J Magn Reson Imaging. 2010; 31(6): 1458-1468.
Doi: 10.1002/jmri.22186
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Korteweg, T; Tintore, M; Uitdehaag, BM; Knol, DL; Vrenken, H; Rovira, A; Frederiksen, J; Miller, DH; Fernando, K; Filippi, M; Agosta, F; Rocca, MA; Fazekas, F; Enzinger, C; Parry, A; Polman, CH; Montalban, X; Barkhof, F
A search for new MRI criteria for dissemination in space in subjects with a clinically isolated syndrome.
Eur Radiol. 2009; 19(9): 2244-2248.
Doi: 10.1007/s00330-009-1402-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Bosnell, R; Wegner, C; Kincses, ZT; Korteweg, T; Agosta, F; Ciccarelli, O; De Stefano, N; Gass, A; Hirsch, J; Johansen-Berg, H; Kappos, L; Barkhof, F; Mancini, L; Manfredonia, F; Marino, S; Miller, DH; Montalban, X; Palace, J; Rocca, M; Enzinger, C; Ropele, S; Rovira, A; Smith, S; Thompson, A; Thornton, J; Yousry, T; Whitcher, B; Filippi, M; Matthews, PM
Reproducibility of fMRI in the clinical setting: implications for trial designs.
Neuroimage. 2008; 42(2): 603-610.
Doi: 10.1016/j.neuroimage.2008.05.005
Web of Science
PubMed
FullText
FullText_MUG
Multiple Sclerosis Therapy Consensus Group (MSTCG); Wiendl, H; Toyka, KV; Rieckmann, P; Gold, R; Hartung, HP; Hohlfeld, R
Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations.
J Neurol. 2008; 255(10):1449-1463
Doi: 10.1007/s00415-008-0061-1
Web of Science
PubMed
FullText
FullText_MUG
Sailer, M; Fazekas, F; Gass, A; Kappos, L; Radue, EW; Rieckmann, P; Toykas, K; Wiendl, H; Bendszus, M
Cerebral and spinal MRI examination in patients with clinically isolated syndrome and definite multiple sclerosis
ROFO-FORTSCHR RONTGENSTRAHL. 2008; 180(11): 994-1001.
Doi: 10.1055/s-2008-1027817
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
De Stefano, N; Filippi, M; Miller, D; Pouwels, PJ; Rovira, A; Gass, A; Enzinger, C; Matthews, PM; Arnold, DL
Guidelines for using proton MR spectroscopy in multicenter clinical MS studies.
Neurology. 2007; 69(20): 1942-1952.
Doi: 10.1212/01.wnl.0000291557.62706.d3
Web of Science
PubMed
FullText
FullText_MUG
Charil, A; Yousry, TA; Rovaris, M; Barkhof, F; De Stefano, N; Fazekas, F; Miller, DH; Montalban, X; Simon, JH; Polman, C; Filippi, M
MRI and the diagnosis of multiple sclerosis: expanding the concept of no better explanation.
LANCET NEUROL 2006 5: 841-852.
Doi: 10.1016/S1474-4422(06)70572-5
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Korteweg, T; Tintoré, M; Uitdehaag, B; Rovira, A; Frederiksen, J; Miller, D; Fernando, K; Filippi, M; Agosta, F; Rocca, M; Fazekas, F; Enzinger, C; Matthews, P; Parry, A; Polman, C; Montalban, X; Barkhof, F
MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study.
LANCET NEUROL. 2006; 5(3): 221-227.
Doi: 10.1016/S1474-4422(06)70353-2
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Reindl, M; Khalil, M; Berger, T
Antibodies as biological markers for pathophysiological processes in MS.
J Neuroimmunol. 2006; 180(1-2):50-62
Doi: 10.1016/j.jneuroim.2006.06.028
Web of Science
PubMed
FullText
FullText_MUG
Barkhof, F; Held, U; Simon, JH; Daumer, M; Fazekas, F; Filippi, M; Frank, JA; Kappos, L; Li, D; Menzler, S; Miller, DH; Petkau, J; Wolinsky, J; Sylvia Lawry Centre for MS Research
Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trials.
Neurology. 2005; 65(9):1447-1454
Doi: 10.1212/01.wnl.0000183149.87975.32
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Enzinger, C; Fazekas, F
Functional MRI in multiple sclerosis: a simple motor task gives insights into a complex disease.
LANCET NEUROL. 2005; 4(10): 589-590.
Doi: 10.1016/S1474-4422(05)70176-9
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Staffen, W; Zauner, H; Mair, A; Kutzelnigg, A; Kapeller, P; Stangl, H; Raffer, E; Niederhofer, H; Ladurner, G
Magnetic resonance spectroscopy of memory and frontal brain region in early multiple sclerosis.
J Neuropsychiatry Clin Neurosci. 2005; 17(3):357-363
Doi: 10.1176/appi.neuropsych.17.3.357
Web of Science
PubMed
FullText
FullText_MUG
Ganzinger, U; Badelt, C; Vass, K; Strasser-Fuchs, S; Fazekas, F; Berger, T; Dahlke, F
Health care costs of multiple sclerosis in Austria. Cross-sectional study including consideration of quality of life
NERVENARZT. 2004; 75(10): 1000-1006.
Doi: 10.1007/s00115-004-1732-5
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Miller, DH; Filippi, M; Fazekas, F; Frederiksen, JL; Matthews, PM; Montalban, X; Polman, CH
Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis.
Ann Neurol. 2004; 56(2):273-278
Doi: 10.1002/ana.20156
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Rieckmann, P; Toyka, KV; Bassetti, C; Beer, K; Beer, S; Buettner, U; Chofflon, M; Götschi-Fuchs, M; Hess, K; Kappos, L; Kesselring, J; Goebels, N; Ludin, HP; Mattle, H; Schluep, M; Vaney, C; Baumhackl, U; Berger, T; Deisenhammer, F; Fazekas, F; Freimüller, M; Kollegger, H; Kristoferitsch, W; Lassmann, H; Markut, H; Strasser-Fuchs, S; Vass, K; Altenkirch, H; Bamborschke, S; Baum, K; Benecke, R; Brück, W; Dommasch, D; Elias, WG; Gass, A; Gehlen, W; Haas, J; Haferkamp, G; Hanefeld, F; Hartung, HP; Heesen, C; Heidenreich, F; Heitmann, R; Hemmer, B; Hense, T; Hohlfeld, R; Janzen, RW; Japp, G; Jung, S; Jügelt, E; Koehler, J; Kölmel, W; König, N; Lowitzsch, K; Manegold, U; Melms, A; Mertin, J; Oschmann, P; Petereit, HF; Pette, M; Pöhlau, D; Pohl, D; Poser, S; Sailer, M; Schmidt, S; Schock, G; Schulz, M; Schwarz, S; Seidel, D; Sommer, N; Stangel, M; Stark, E; Steinbrecher, A; Tumani, H; Voltz, R; Weber, F; Weinrich, W; Weissert, R; Wiendl, H; Wiethölter, H; Wildemann, U; Zettl, UK; Zipp, F; Zschenderlein, R; Izquierdo, G; Kirjazovas, A; Packauskas, L; Miller, D; Koncan Vracko, B; Millers, A; Orologas, A; Panellus, M; Sindic, CJ; Bratic, M; Svraka, A; Vella, NR; Stelmasiak, Z; Selmaj, K; Bartosik-Psujik, H; Mitosek-Szewczyk, K; Belniak, E; Mochecka, A; Bayas, A; Chan, A; Flachenecker, P; Gold, R; Kallmann, B; Leussink, V; Mäurer, M; Ruprecht, K; Stoll, G; Weilbach, FX; Multiple Sclerosis Therapy Consensus Group
Escalating immunotherapy of multiple sclerosis--new aspects and practical application.
J Neurol. 2004; 251(11):1329-1339
Doi: 10.1007/s00415-004-0537-6
Web of Science
PubMed
FullText
FullText_MUG
Bammer, R; Fazekas, F
Diffusion imaging in multiple sclerosis.
Neuroimaging Clin N Am. 2002; 12(1):71-106
Doi: 10.1016/S1052-5149(03)00071-6
Web of Science
PubMed
FullText
FullText_MUG
Kapeller, P; Brex, PA; Chard, D; Dalton, C; Griffin, CM; McLean, MA; Parker, GJ; Thompson, AJ; Miller, DH
Quantitative 1H MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis.
Mult Scler. 2002; 8(3):207-210
Doi: 10.1191%2F1352458502ms822oa
Web of Science
PubMed
FullText
FullText_MUG
Beer, M; Sandstede, J; Weilbach, F; Spindler, M; Buchner, S; Krug, A; Kostler, H; Pabst, T; Kenn, W; Landschutz, W; von Kienlin, M; Toyka, KV; Ertl, G; Gold, R; Hahn, D
Cardiac metabolism and function in patients with multiple sclerosis: A combined P-31-MR-spectroscopy and MRI study
Rofo. 2001; 173(5):399-404
Doi: 10.1055/s-2001-13339
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Comi, G; Filippi, M; Barkhof, F; Durelli, L; Edan, G; Fernández, O; Hartung, H; Seeldrayers, P; Sørensen, PS; Rovaris, M; Martinelli, V; Hommes, OR; Early Treatment of Multiple Sclerosis Study Group
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study.
Lancet. 2001; 357(9268):1576-1582
Doi: 10.1016%2FS0140-6736%2800%2904725-5
Web of Science
PubMed
FullText
FullText_MUG
Krenn, M; Bonelli, RM; Niederwieser, G; Reisecker, F; Költringer, P
Adrenoleukodystrophy mimicking multiple sclerosis
Nervenarzt. 2001; 72(10):794-797
Doi: 10.1007/s001150170037
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Zwick, EB; Saraph, V; Strobl, W; Steinwender, G
Single event multilevel surgery to improve gait in diplegic cerebral palsy - a prospective controlled trial
Z Orthop Ihre Grenzgeb. 2001; 139(6): 485-489.
Doi: 10.1055/s-2001-19228
Web of Science
PubMed
FullText
FullText_MUG
Fazekas, F; Strasser-Fuchs, S; Schmidt, H; Enzinger, C; Ropele, S; Lechner, A; Flooh, E; Schmidt, R; Hartung, HP
Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis.
J Neurol Neurosurg Psychiatry. 2000; 69(1):25-28
Doi: 10.1136%2Fjnnp.69.1.25
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Fazekas, F; Offenbacher, H; Hartung, HP
What is the role of ancillary investigations in establishing the diagnosis of multiple sclerosis?
Eur Neurol. 1997; 38(4):255-257
Doi: 10.1159/000113390
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Walther, EU; Dang, T; Hartung, HP; Hohlfeld, R
Formation of neutralizing antibodies in therapy of multiple sclerosis with interferon beta-1b. Practical procedure in suspected therapeutic failure
Nervenarzt. 1997; 68(12):935-939
Doi: 10.1007/s001150050219
Web of Science
PubMed
FullText
FullText_MUG
Offenbacher, H; Fazekas, F; Schmidt, R; Freidl, W; Flooh, E; Payer, F; Lechner, H
Assessment of MRI criteria for a diagnosis of MS.
NEUROLOGY 1993 43: 905-909.
Doi: 10.1212/WNL.43.5.905
Web of Science
PubMed
FullText
FullText_MUG
Millner, MM; Ebner, F; Justich, E; Urban, C
Multiple sclerosis in childhood: contribution of serial MRI to earlier diagnosis.
Dev Med Child Neurol. 1990; 32(9):769-777
Doi: 10.1111/j.1469-8749.1990.tb08480.x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Fazekas, F; Offenbacher, H; Fuchs, S; Schmidt, R; Niederkorn, K; Horner, S; Lechner, H
Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis.
Neurology. 1988; 38(12):1822-1825
Doi: 10.1212/WNL.38.12.1822
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Ladurner, G; Schraml, H; Sager, WD; Flooh, E; Lepuschütz, H; Lechner, H
Results of clinical investigation in patients with multiple sclerosis (author's transl)
Nervenarzt. 1981; 52(6):340-343
Web of Science
PubMed